Good post. I tend to agree with your sentiments.
"- how exactly, well that's a different question."
This is my consideration at present too. The options have to be either cancelled or exercised as a part of any full buyout scenario. I do not believe that MT & the board would attempt to force through a deal with no consideration for options (but I have been wrong before, on occasion).
Here is the spread on what was paid to various option holders in the Resapp deal for anyone that's interested:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-682
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $86.20K | 429.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 67508 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 36444 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |